Mission Therapeutics Limited

Research activity is centred on Parkinson's disease, with clinical interest in the neurological mechanisms underlying movement impairment and disease progression. The sponsor’s funded trial landscape is focused on central nervous system disorders, particularly conditions affecting motor control and neurodegeneration.

• Parkinson's disease
• Movement disorders
• Neurodegeneration

Clinical research activity in this area reflects an interest in therapeutic approaches aimed at the neurological symptoms and biological drivers of Parkinsonian syndromes.